ATE268782T1 - Zusammensetzungen zur wundheilung - Google Patents

Zusammensetzungen zur wundheilung

Info

Publication number: ATE268782T1
Authority: AT; Austria
Prior art keywords: wound healing; compositions; angiotensin; analogs; mammals
Prior art date: 1997-12-12

Application number

AT98963073T

Other languages

English (en)

Inventor

Kathleen Rodgers

Gere S Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-12

Filing date

1998-12-11

Publication date

2004-06-15

1998-12-11 Application filed by Univ Southern California filed Critical Univ Southern California

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE268782T1 publication Critical patent/ATE268782T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
230000029663 wound healing Effects 0.000 title abstract 2
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 2
102000005862 Angiotensin II Human genes 0.000 abstract 1
101800000733 Angiotensin-2 Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
229950006323 angiotensin ii Drugs 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Materials Engineering (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Immunology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

AT98963073T 1997-12-12 1998-12-11 Zusammensetzungen zur wundheilung ATE268782T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6966297P	1997-12-12	1997-12-12
PCT/US1998/026347 WO1999031125A1 (en)	1997-12-12	1998-12-11	Wound healing compositions

Publications (1)

Publication Number	Publication Date
ATE268782T1 true ATE268782T1 (de)	2004-06-15

Family

ID=22090435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98963073T ATE268782T1 (de)	1997-12-12	1998-12-11	Zusammensetzungen zur wundheilung

Country Status (9)

Country	Link
US (3)	US6165978A (de)
EP (1)	EP1036089B1 (de)
JP (1)	JP4347522B2 (de)
AT (1)	ATE268782T1 (de)
AU (1)	AU755225B2 (de)
CA (1)	CA2315266C (de)
DE (1)	DE69824445T2 (de)
TW (1)	TW542843B (de)
WO (1)	WO1999031125A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
ATE268782T1 (de) *	1997-12-12	2004-06-15	Univ Southern California	Zusammensetzungen zur wundheilung
JP2002509077A (ja)	1998-02-09	2002-03-26	ユニヴァースティオブサザーンカリフォルニア	赤血球形成促進方法
WO1999058140A1 (en) *	1998-05-11	1999-11-18	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
ATE250423T1 (de)	1998-07-13	2003-10-15	Univ Southern California	Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
AU755943B2 (en)	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
WO2001055176A2 (en) *	2000-01-27	2001-08-02	University Of Southern California	Methods for inhibiting smooth muscle cell proliferation
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
AU2002308522A1 (en) *	2001-05-01	2002-11-11	University Of Southern California	Methods for inhibiting tumor cell proliferation
US7094252B2 (en) *	2001-08-21	2006-08-22	Cooltouch Incorporated	Enhanced noninvasive collagen remodeling
JP2005530768A (ja)	2002-05-09	2005-10-13	メディジーンズ	血漿または血清を含有した創傷治療用医薬組成物
DE10361306A1 (de) *	2003-12-24	2005-07-28	Lts Lohmann Therapie-Systeme Ag	Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
BRPI0602372B8 (pt) *	2006-05-18	2021-06-22	Einco Biomaterial Ltda	processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado
US20090227507A1 (en) *	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
NZ594302A (en) *	2008-12-29	2013-07-26	Trevena Inc	Beta-arrestin effectors and compositions and methods of use thereof
WO2011120032A1 (en) *	2010-03-26	2011-09-29	University Of Southern California	Methods for treating combined radiation and thermal injury
US10279007B2 (en)	2010-11-15	2019-05-07	Oxygenetix Institute, Inc.	Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
WO2012106427A2 (en)	2011-02-02	2012-08-09	University Of Southern California	Methods for treating diabetic foot ulcers
JP2015504870A (ja) *	2011-12-16	2015-02-16	タリックスファーマシューティカルズリミテッド	線維症を処置するためのアンジオテンシン
WO2013116312A1 (en)	2012-01-31	2013-08-08	Trevena, Inc.	ß-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
WO2013172956A1 (en)	2012-05-14	2013-11-21	University Of Southern California	Methods for limiting development of a skin wound
ES2834430T3 (es)	2013-03-15	2021-06-17	Univ Southern California	Procedimientos, compuestos y composiciones para el tratamiento de enfermedades relacionadas con la angiotensina
US9623084B2 (en)	2013-03-15	2017-04-18	University Of Southern California	Methods for treating multiple sclerosis
AU2014259948B2 (en) *	2013-04-30	2019-04-18	University Of Southern California	Accelerated healing of eye injuries by angiotensin peptides
AU2014284496A1 (en)	2013-07-03	2016-01-21	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method for treating cognitive dysfunction
US9518086B2 (en)	2014-02-07	2016-12-13	Trevena, Inc.	Crystalline and amorphous forms of a β-arrestin effector
AU2015264367A1 (en)	2014-05-19	2016-12-15	Trevena, Inc.	Synthesis of Beta-Arrestin Effectors
CN106535920B (zh)	2014-07-21	2020-10-30	代表亚利桑那大学的亚利桑那校董会	Ang-(1-7)衍生物寡肽及其使用和生产方法
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
EP3548035A4 (de)	2016-11-30	2020-07-22	Case Western Reserve University	Kombinationen von 15-pgdh-inhibitoren mit corticosteroiden und/oder tnf-inhibitoren und verwendungen davon
CN110573154A (zh)	2017-02-06	2019-12-13	卡斯西部储备大学	调节短链脱氢酶活性的组合物和方法
WO2020106998A1 (en)	2018-11-21	2020-05-28	Case Western Reserve University	Compositions and methods of modulating short-chain dehydrogenase activity
KR102668789B1 (ko)	2018-11-23	2024-05-24	(주)메디코스바이오텍	창상치료용 약학조성물
AU2021224268A1 (en)	2020-02-21	2022-09-15	Case Western Reserve University	Compositions and methods for treating renal injury
CR20220654A (es)	2020-05-20	2023-08-24	Rodeo Therapeutics Corp	Composiciones y métodos para modular la actividad de deshidrogenasas de cadena corta
AU2024381905A1 (en)	2023-11-15	2026-06-25	Xitra Therapeutics Gmbh	Small molecule modulators of mas and mrgd receptors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair
EP1333034B1 (de) *	1993-09-24	2010-07-14	University Of Southern California	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
PT730465E (pt) *	1993-09-24	2002-06-28	Univ Southern California	Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) *	1995-06-06	1998-11-10	The University Of Southern California	Use of angiotensin II Type 2 receptor agonists in tissue repair
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en) *	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
ATE268782T1 (de) *	1997-12-12	2004-06-15	Univ Southern California	Zusammensetzungen zur wundheilung
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue

1998
- 1998-12-11 AT AT98963073T patent/ATE268782T1/de not_active IP Right Cessation
- 1998-12-11 WO PCT/US1998/026347 patent/WO1999031125A1/en not_active Ceased
- 1998-12-11 US US09/210,249 patent/US6165978A/en not_active Expired - Lifetime
- 1998-12-11 CA CA002315266A patent/CA2315266C/en not_active Expired - Fee Related
- 1998-12-11 JP JP2000539048A patent/JP4347522B2/ja not_active Expired - Fee Related
- 1998-12-11 DE DE69824445T patent/DE69824445T2/de not_active Expired - Lifetime
- 1998-12-11 EP EP98963073A patent/EP1036089B1/de not_active Expired - Lifetime
- 1998-12-11 AU AU18177/99A patent/AU755225B2/en not_active Ceased
- 1998-12-14 TW TW087120706A patent/TW542843B/zh not_active IP Right Cessation
2000
- 2000-10-27 US US09/698,354 patent/US6455501B1/en not_active Expired - Lifetime
2002
- 2002-08-06 US US10/213,701 patent/US7022675B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4347522B2 (ja)	2009-10-21
US20030017970A1 (en)	2003-01-23
US6455501B1 (en)	2002-09-24
CA2315266A1 (en)	1999-06-24
DE69824445D1 (de)	2004-07-15
EP1036089B1 (de)	2004-06-09
EP1036089A1 (de)	2000-09-20
WO1999031125B1 (en)	1999-08-19
TW542843B (en)	2003-07-21
CA2315266C (en)	2004-08-10
JP2002508391A (ja)	2002-03-19
AU755225B2 (en)	2002-12-05
DE69824445T2 (de)	2005-06-30
US7022675B2 (en)	2006-04-04
AU1817799A (en)	1999-07-05
WO1999031125A1 (en)	1999-06-24
US6165978A (en)	2000-12-26

Legal Events

Date	Code	Title	Description
2004-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69824445D1 (de)	2004-07-15	Zusammensetzungen zur wundheilung
DE60042578D1 (de)	2009-09-03	Vorrichtung zur elektrochemischen Erzeugung von Sauerstoff
TR199801679T2 (xx)	2001-06-21	Osteoporoz i�in birle�tirme terapisi.
DK0730465T3 (da)	2002-04-08	Anvendelse af angiotensin III og analoger dertil til vævsreparation
FI971610A7 (fi)	1997-04-16	Menetelmä syklisten depsipeptidien sulfonyloimiseksi, sulfenyloimiseks i, ja fosforyloimiseksi
ATE353630T1 (de)	2007-03-15	Inhalationssystem
DE69923979D1 (de)	2005-04-07	Vorrichtung zur erzeugung von ionenstrahlen
PT970095E (pt)	2004-03-31	Novos inibidores benzimidazole de frutose-1,6-bisfosfatase
ES2191830T3 (es)	2003-09-16	Inhibidores de trombina.
ATE255632T1 (de)	2003-12-15	Immortalisierung bzw. desimmortalisierung von zellen
TR200000374T2 (tr)	2000-09-21	Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
TR199900310T2 (xx)	1999-04-21	Trombin inhibit�rleri
EE9700081A (et)	1997-10-15	Keratinotsüüdi kasvufaktori analoogid
DE59810077D1 (de)	2003-12-11	Vorrichtung zur erzeugung von plasma
DE59915175D1 (de)	2010-07-29	Vorrichtung zur Erzeugung von Plasma
DE69513027D1 (de)	1999-12-02	Verfahren zur bestimmung des präthrombotischen status
BR0114595A (pt)	2003-09-16	Uso de um composto que rompe esteróide sexual que sinaliza para o timo no tratamento de um distúrbio de células t
DE60021590D1 (de)	2005-09-01	Verwendung von baclofen zur behandlung von alkoholismus
EA200000519A1 (ru)	2000-10-30	2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
PT783521E (pt)	2003-02-28	Compostos polipeptidos que contem d-2-alquiltriptofano capazes de promover a libertacao da hormona do crescimento
ES2186807T3 (es)	2003-05-16	Inhibidores de trombina.
IL139144A0 (en)	2001-11-25	Mycobacterial inhibitors
DE69824862D1 (de)	2004-08-05	Zusammenstellungen zur verbesserten wundheilung
DE69904566D1 (de)	2003-01-30	Plasmabehandlung zur erzeugung von elektronenquellen
DE69629922D1 (de)	2003-10-16	Vorrichtung zur Konzentrationsmessung von Wasserstoffperoxid